Israel's Generic COVID-19 Drug Licensing Lacks Due Process
At the end of last week, the Israeli attorney general authorized the issuance of a special compulsory license to allow the importation of generic versions of Abbvie Inc.'s patented Kaletra to...To view the full article, register now.
Already a subscriber? Click here to view full article